window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : May 3, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Precision medicine

  • Clinical Trials,Drug Delivery & Formulation,Oncology,Patient Centricity,Precision medicine,Technology and platforms

    Can cryoablation plus intratumora immunotherapy rewrite the rules of cancer treatment?

    Q&A with Dr Jason Williams, founder of the Williams Cancer [...]

    June 26, 2025
  • Drug Delivery & Formulation,Drug Development,Precision medicine

    UK poised to lead in functional genomics, BIA says

    The BioIndustry Association (BIA) has released a new explainer highlighting [...]

    June 13, 2025
  • Biologics & Biosimilars,Precision medicine

    Enhanced Genomics appoints biotech veteran Dietrich Stephan as chair to drive next-gen target discovery

    Enhanced Genomics has appointed leading biotechnology entrepreneur Dietrich Stephan as [...]

    June 12, 2025
  • Drug Development,Precision medicine

    Elkedonia raises EUR 11.25 million to develop new treatment for depression and other neuropsychiatric disorders

    New approach targets Elk1 to restore neuroplasticity without sedation or [...]

    June 12, 2025
  • Clinical Trials,Drug Development,Market Access & Commercialization,Precision medicine,Technology and platforms,Uncategorised

    Veeva unveils bold vision for simplifying, standardising, and AI-powered innovation

    In a keynote address that signaled both reflection and momentum, [...]

    June 5, 2025
  • Market Access & Commercialization,Precision medicine

    Faster equine respiratory disease testing with bioMérieux’s new Vetfire PCR panel

    With Vetfire, bioMérieux enters the veterinary PCR market with an [...]

    June 4, 2025
  • Biologics & Biosimilars,Precision medicine,Regulatory Affairs

    Protagonist and Takeda present VERIFY data on rusfertide showing strong results in polycythemia vera

    Protagonist and Takeda have shared full 32-week results from the [...]

    June 2, 2025
  • CDMOs & Manufacturing,Cell & Gene Therapy,Clinical Trials,Patient Centricity,Precision medicine

    ScaleReady awards multiple G-Rex grants to USC and Children’s Hospital of Los Angeles Investigators

    ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation, and [...]

    May 28, 2025
  • Artificial Intelligence,Drug Development,Partnerships & Funding,Precision medicine,Technology and platforms

    Biostate AI raises $12M to build the ‘Netflix’ of molecular diagnostics using RNAseq and GenAI

    Biostate AI has raised $12 million in Series A funding [...]

    May 23, 2025
  • Drug Development,Partnerships & Funding,Patient Centricity,Precision medicine

    Cinclus Pharma signs €220m Europe deal with Zentiva for GERD drug

    Cinclus Pharma has partnered with Zentiva to commercialize and manufacture [...]

    May 22, 2025
Previous678Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Click Therapeutics secures $50M from Boehringer Ingelheim for schizophrenia digital therapy
    Categories: Clinical Development, Clinical Trials, Digital Health, Funding, Mental health, Neurosciences, Pharmaceuticals and therapeutics
  • Kainova Therapeutics doses first patient in Europe in phase 1/2 anti-CCR8 antibody trial
    Categories: Clinical Trials, Oncology
  • START appoints Salwan Al Mutar to lead clinical research in Dallas-Fort Worth
    Categories: Clinical Development, Clinical Trials, Healthcare leadership, Oncology
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top